To Evaluate the Safety and PK Characteristics After Co-administration of JW0104 and C2402 and Administration of JW0105

Launched by JW PHARMACEUTICAL · Dec 23, 2024

Keywords

ClinConnect Summary

This clinical trial is looking to understand how safe a combination of two substances, JW0104 and C2402, is when taken together, as well as how they are processed in the body. In addition, the study will also examine another substance, JW0105, on its own. The trial will take place with healthy volunteers who will be fasting, meaning they won’t eat anything before the study.

To be eligible for this trial, participants need to be healthy adults aged between 18 and 65 years old. There are no specific exclusions other than not meeting the health criteria. While the trial is not yet recruiting participants, those who join can expect to help researchers learn more about these substances and their effects, which could contribute to future medical advancements.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Healthy volunteers
• Exclusion Criteria:
• • Subjects does not meet the inclusion Criteria